Brief: Newron Pharmaceuticals FY Net Loss Narrows To EUR 5.28 Million

Newron Pharmaceuticals SpA

01/03/2018 06:07

March 1 (Reuters) - NEWRON PHARMACEUTICALS SPA  NWRN.S :
    * FY TOTAL REVENUES SUBSTANTIALLY INCREASED TO EUR 13.4
MILLION
FROM EUR 6.7 MILLION (2016)
    * FY INCREASED LICENSE INCOME (EUR 10.4 MILLION IN 2017
VERSUS.
EUR 3.0 MILLION IN 2016)
    * ‍FY NET LOSS EUR 5.28 MILLION VERSUS NET LOSS EUR 15.24​
MILLION
YEAR AGO

Source text for Eikon:  ID:nBw5TyWdla 
Further company coverage:  NWRN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))